Fang Xu

Dr. Fang Xu


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 November 2022 in European Journal of Clinical Microbiology & Infectious Diseases
Verified
Journal Article
Closed access
PDF file
ZRZhuxiao Ren
Zhuxiao Ren
SYShumei Yang
Shumei Yang
JHJiangxue Han
Jiangxue Han
CNChuan Nie
Chuan Nie
CWCuicui Wang
Cuicui Wang
JYJie Yang
Jie Yang

11 September 2020 in Italian Journal of Pediatrics
Verified
Journal Article
Open access
PDF file
JMJiayu Miao
Jiayu Miao
ZRZhuxiao Ren
Zhuxiao Ren
YRYunbei Rao
Yunbei Rao
XXXin Xia
Xin Xia
JWJianlan Wang
Jianlan Wang
JYJie Yang
Jie Yang
Objective: To investigate the effect of pathological staging of chorioamnionitis (CA) on complications in preterm infants;Methods: A single-center, retrospective study was conducted to choose singleton preterm infants (gestational age < 37 weeks) from the Department of Obstetrics and Gynecology in our hospital from December 2016 to December 2017. The basic data and placental pathological results were retrospectively collected. According to the placental pathological results of whether inflammation infiltrating amnion, CA 0/I phase was classified into non-amnionitis group, CA II/III phase was classified into amnionitis group, the incidence of common complications in preterm infants was compared. Further, logistic regression was used to analyze the effects of amnionitis on complications after being adjusted to gestational age, birth weight and thrombocytopenia.Results: A total of 221 preterm infants were enrolled, including 186 cases in non-amnionitis group and 35 cases in amnionitis group. The gestational age of amnionitis group (32.00 ± 2.71 weeks) was significantly lower than non-amnionitis group (34.14 ± 2.06 weeks), birth weight (1.93 ± 0.64 kg) was significantly lower than that of non-amnionitis group (2.26 ± 0.58 kg), and the hospital stay in amnionitis group was significantly longer (25.71 ± 19.23 days), all of the difference above was statistically significant(P < 0.05). The incidence of intraventricular hemorrhage (IVH) in amnionitis group (37.14%) was significantly higher than that in non-amnionitis group (13.98%) (P = 0.002), and the risk of IVH was significantly increased by amnionitis (OR = 3.636, 95%CI: 1.632–8.102); after correction of gestational age, birth weight and thrombocytopenia, the risk of IVH was still significantly increased (OR = 2.471,P = 0.046, 95% CI: 1.015–6.015). And the late-onset IVH was more common (P = 0.009).Conclusion: Amnionitis leads to a significant reduction in gestational age and birth weight in preterm infants, and it is an independent risk factor for IVH.

17 April 2024 in iScience
Verified
Journal Article
Open access
ZRZhuxiao Ren
Zhuxiao Ren
YSYang Shuo
Yang Shuo
HJHan Jiangxue
Han Jiangxue
PJPei Jingjun
Pei Jingjun
ZQZhang Qi
Zhang Qi
JYJie Yang
Jie Yang
Stem cell therapy may prevent late-onset sepsis (LOS) via antimicrobial peptide LL37 secretion and regulatory T cell (Treg) regulation. The early prediction of LOS is still a challenge. This study evaluated whether immunological state of LL37 or Tregs precedes LOS. We firstly analyzed the LL37 level, Treg proportion, and LOS incidence in very preterm infants treated with autologous cord blood mononuclear cells (ACBMNCs) in our previous trial. Then, we constructed a prediction model and built validation cohort. We found ACBMNC intervention reduced the incidence of LOS from 27.3% to 6.9% (p = 0.021). LL37 and Treg abundances were higher in the ACBMNCs group. The nomogram demonstrated that early-life Treg and LL37 characteristics were closely associated with LOS (area under the curve, AUC 0.936), with implications for early prediction and timely clinical management. This composite model was also helpful to evaluate the beneficial effect of ACBMNCs intervention on LOS, thus promoting translational research.

1 July 2021 in Pediatrics & Neonatology
Verified
Journal Article
Open access
ZRZhuxiao Ren
Zhuxiao Ren
JWJianlan Wang
Jianlan Wang
RLRunqiang Liang
Runqiang Liang
YLYingyi Lin
Yingyi Lin
FXFang Xu
Fang Xu
JYJie Yang
Jie Yang

2 September 2023 in Indian Journal of Pediatrics
Verified
Journal Article
Closed access
PDF file
ZRZhuxiao Ren
Zhuxiao Ren
YSYang Shumei
Yang Shumei
ZQZhang Qi
Zhang Qi
FXFang Xu
Fang Xu
OHOn Behalf of the Quality Improvement Cooperative Group in NCIU in Guangdong Women and Children Hospital
On Behalf of the Quality Improvement Cooperative Group in NCIU in Guangdong Women and Children Hospital
HYHuang Yongzhi
Huang Yongzhi

28 April 2026 in Stem Cell Reviews and Reports
Verified
Journal Article
Closed access
PDF file
ZRZhuxiao Ren
Zhuxiao Ren
CNChuan Nie
Chuan Nie
FXFang Xu
Fang Xu
WGWeiwei Gao
Weiwei Gao
SYShumei Yang
Shumei Yang
JYJie Yang
Jie Yang